TopotecanAcute exacerbation of interstitial lung disease characterised as pneumonitis: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2016年 / 1583卷 / 1期

关键词：

D O I：

10.1007/s40278-016-12597-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1059 / 1059

相关论文

共 50 条

[41] Emphysema mimicking interstitial lung disease: Two case reports
Juhl, Kasper S.
Bendstrup, Elisabeth
Rasmussen, Finn
Hilberg, Ole
RESPIRATORY MEDICINE CASE REPORTS, 2015, 15 : 24 - 26
[42] Adalimumab/etanerceptExacerbation of interstitial lung disease: 2 case reports
Reactions Weekly, 2010, 1319 (1) : 8 - 8
[43] Adalimumab/etanerceptExacerbation of the interstitial lung disease: 2 case reports
Reactions Weekly, 2017, 1679 (1) : 15 - 15
[44] Nivolumab/osimertinibHepatotoxicity and interstitial lung disease: 3 case reports
Reactions Weekly, 2017, 1668 (1) : 309 - 309
[45] AfatinibDiarrhoea, interstitial lung disease and paronychia: 3 case reports
Reactions Weekly, 2021, 1837 (1) : 30 - 30
[46] Adalimumab/methotrexateBronchiolitis and interstitial lung disease: 2 case reports
Reactions Weekly, 2017, 1653 (1) : 24 - 24
[47] Adalimumab/etanerceptWorsening of interstitial lung disease: 2 case reports
Reactions Weekly, 2017, 1668 (1) : 23 - 23
[48] Etanercept/methotrexateAcceleration of interstitial lung disease: 2 case reports
Reactions Weekly, 2006, 1116 (1) : 14 - 14
[49] EtanerceptInterstitial lung disease acute exacerbation and drug-induced pneumonitis: case report
Reactions Weekly, 2015, 1571 (1) : 95 - 95
[50] Erlotinib/gefitinibHepatotoxicity, interstitial lung disease and lupus-like rash: 5 case reports
Reactions Weekly, 2012, 1416 (1) : 22 - 22

← 1 2 3 4 5 →